Description

AOD9604 peptides is a synthetic peptide fragment derived from human growth hormone (HGH). It corresponds to the 176–191 amino acid sequence of growth hormone, which researchers study for its potential role in fat metabolism and lipolysis. Top 10 peptides trending in 2026 for fat-loss research.

The peptide was originally developed for obesity and metabolic research, as it mimics certain metabolic effects of growth hormone without affecting growth-related pathways. AOD9604 Peptide

What AOD9604 Is

AOD9604 is often referred to as a growth hormone fragment peptide. Researchers investigate it because it appears to stimulate fat breakdown while reducing fat storage in experimental models.

Basic characteristics

• Peptide fragment of human growth hormone (HGH)

• Consists of 16 amino acids

• Designed to target lipolysis pathways

• Commonly studied in metabolic and obesity research

How AOD9604 Works

In research models, AOD9604 may influence metabolism through two main processes:

1️⃣ Lipolysis Activation

It may stimulate lipolysis, the process where stored fat is broken down into fatty acids.

2️⃣ Lipogenesis Inhibition

It may reduce lipogenesis, the formation of new fat cells.

These mechanisms make AOD9604 a subject of interest in studies related to fat metabolism and weight regulation.

Potential Research Areas

Scientists have investigated AOD9604 in studies related to:

• obesity and body fat metabolism

• lipid metabolism pathways

• metabolic disorders

• cellular energy regulation

Some experimental research suggests the peptide may influence fat oxidation without affecting blood sugar levels.

Forms Used in Research

AOD9604 is typically supplied as:

• lyophilized peptide powder in vials

• capsules or oral research formulations

Laboratory products often report ≥98–99% purity verified by analytical methods such as HPLC.

Storage and Handling

For research stability:

• Store at 2–8 °C (refrigerated)

• Keep in a dry, dark environment

• Reconstituted solutions should be used according to laboratory protocols.

Regulatory Status

Important considerations:

• AOD9604 is not approved by the U.S. FDA as a medication

• It is generally sold as a research compound

• Most suppliers label it “for research use only.”

Summary

AOD9604 is a synthetic peptide derived from the 176–191 fragment of human growth hormone. Researchers study it primarily for its potential effects on fat metabolism and lipolysis. While early studies have explored its metabolic properties, the compound remains experimental and not approved for medical use.